Matches in Wikidata for { <http://www.wikidata.org/entity/Q64807289> ?p ?o ?g. }
Showing items 1 to 34 of
34
with 100 items per page.
- Q64807289 description "clinical trial" @default.
- Q64807289 description "ensayu clínicu" @default.
- Q64807289 description "klinisch onderzoek" @default.
- Q64807289 description "клінічне випробування" @default.
- Q64807289 name "Salmeterol/Fluticasone 50/500 mcg Inhalation Powder Via Capsair vs Seretide Diskus 500 mcg Inhalation Powder in Patients With COPD" @default.
- Q64807289 type Item @default.
- Q64807289 label "Salmeterol/Fluticasone 50/500 mcg Inhalation Powder Via Capsair vs Seretide Diskus 500 mcg Inhalation Powder in Patients With COPD" @default.
- Q64807289 prefLabel "Salmeterol/Fluticasone 50/500 mcg Inhalation Powder Via Capsair vs Seretide Diskus 500 mcg Inhalation Powder in Patients With COPD" @default.
- Q64807289 P1132 Q64807289-63B622AF-F42D-4ACD-87D8-235F8D503EDE @default.
- Q64807289 P1476 Q64807289-5C0A541E-4283-4618-8387-898A463DA442 @default.
- Q64807289 P17 Q64807289-091144BF-C4A3-47C4-B794-5A57A078D11E @default.
- Q64807289 P1813 Q64807289-E6E53E74-1394-4B6C-922E-F5809F0899A2 @default.
- Q64807289 P2899 Q64807289-B53F908A-B53E-49DF-9593-4FA0B9EFC3DB @default.
- Q64807289 P3098 Q64807289-2503E5FE-1C12-4349-8793-10E804AAC49C @default.
- Q64807289 P31 Q64807289-4CA11A09-A273-4BB8-84A1-51AA59FB12E8 @default.
- Q64807289 P4135 Q64807289-8B8FDEAD-4D8F-4C28-A464-3C9CD21628D7 @default.
- Q64807289 P4844 Q64807289-22017BE9-8045-49F2-AAF0-EA7AF8A7CFCF @default.
- Q64807289 P580 Q64807289-88D8ED6A-507D-467E-89E2-31104CA8BE3C @default.
- Q64807289 P582 Q64807289-E7C5F947-D097-4C42-84D2-DCA0F226915F @default.
- Q64807289 P6099 Q64807289-03576B79-BEFA-465F-8CBE-E47FE5EE17FD @default.
- Q64807289 P8363 Q64807289-EC757B51-16AD-408D-BD0B-DF093DADAF3E @default.
- Q64807289 P1132 "+64" @default.
- Q64807289 P1476 "Comparison of Efficacy and Safety of Salmeterol/Fluticasone 50/500 mcg Inhalation Powder Treatment Administered Via Capsair and Original Product Seretide Diskus 500 mcg Inhalation Powder Treatment in Patients With Moderate-severe Chronic Obstructive Pulmonary Disease (COPD)" @default.
- Q64807289 P17 Q43 @default.
- Q64807289 P1813 "COPD" @default.
- Q64807289 P2899 "+40" @default.
- Q64807289 P3098 "NCT03363503" @default.
- Q64807289 P31 Q30612 @default.
- Q64807289 P4135 "+100" @default.
- Q64807289 P4844 Q27264747 @default.
- Q64807289 P580 "2018-01-01T00:00:00Z" @default.
- Q64807289 P582 "2019-01-01T00:00:00Z" @default.
- Q64807289 P6099 Q42825046 @default.
- Q64807289 P8363 Q78089383 @default.